The type of diabetes you can be born with is called neonatal diabetes mellitus, a rare genetic condition that appears in the first 6 to 12 months of life. It is not the same as Type 1 or Type 2 diabetes. While many people assume Type 1 diabetes is something you’re born with, it actually develops later, with a median age of diagnosis around 24 years and a peak around age 15.
What Neonatal Diabetes Is
Neonatal diabetes mellitus (NDM) is caused by a mutation in a single gene that disrupts the body’s ability to produce or release insulin. Unlike Type 1 diabetes, which is an autoimmune disease where the immune system attacks insulin-producing cells over time, neonatal diabetes is hardwired into a baby’s DNA from conception. The defect is present from the start, which is why symptoms show up so early in life.
Babies who develop diabetes before 6 months of age almost always have a form of NDM rather than Type 1. Doctors typically recommend genetic testing for any infant diagnosed with diabetes at 6 months or younger, because confirming the specific gene involved changes how the condition is treated.
What Causes It
Most cases of permanent neonatal diabetes trace back to mutations in one of three genes. Two of these genes (KCNJ11 and ABCC8) control tiny channels on the surface of insulin-producing cells in the pancreas. Normally, these channels close in response to rising blood sugar, which triggers the cell to release insulin. When the channels are defective, they stay open, and the cell never gets the signal to release insulin into the bloodstream.
A third gene, responsible for building the insulin molecule itself, accounts for roughly 20 to 25 percent of permanent neonatal diabetes cases. Mutations in this gene cause the body to produce insulin that is misfolded or incomplete, so even though the pancreas tries to make it, the final product doesn’t work properly. The result in all three scenarios is the same: blood sugar rises because functional insulin isn’t reaching the rest of the body.
Transient vs. Permanent Forms
Neonatal diabetes comes in two forms, and the distinction matters a great deal for families. The transient form gradually improves on its own, with symptoms typically fading between 3 and 18 months of age. For a while, the child may appear to have outgrown the condition entirely. But this remission isn’t always permanent. Up to half of children with the transient form develop diabetes again later in life, often triggered by illness or, in women, pregnancy.
The permanent form never goes into remission. It requires lifelong management from the point of diagnosis. Genetic testing is the only reliable way to determine which form a baby has, and it also guides the choice of treatment.
Signs in Newborns
Neonatal diabetes often leaves clues before a baby is even born. Affected fetuses tend to grow poorly in the womb, and many are noticeably small for their gestational age at delivery. After birth, the signs mirror what you’d expect from high blood sugar at any age, just in miniature. Parents may notice an unusually high number of wet diapers, because excess glucose spills into the urine and pulls water along with it. Increased appetite and signs of dehydration, like dry mouth or sunken soft spots on the skull, are also common early indicators.
How Treatment Differs From Type 1
This is where genetic testing becomes especially powerful. For babies with mutations in the KCNJ11 or ABCC8 genes, more than 90 percent can eventually stop insulin injections entirely and switch to an oral medication that directly closes those faulty channels on the pancreas cells. The medication essentially does the job the broken channel can’t, restoring near-normal insulin release. Children tend to respond better than adults, and blood sugar control often improves significantly after the switch.
Not every genetic variant responds to oral treatment, and people who attempt the transition as adults, particularly after age 30, are less likely to succeed and typically need higher doses. For babies whose neonatal diabetes stems from a defective insulin gene rather than a channel problem, insulin therapy remains the standard approach, since the issue is the insulin molecule itself rather than the mechanism that releases it.
Why Type 1 Diabetes Isn’t Present at Birth
Type 1 diabetes is often described as a childhood disease, which leads many people to assume it’s something you’re born with. In reality, Type 1 is an autoimmune process that unfolds over months or years. The immune system gradually destroys the insulin-producing cells in the pancreas until too few remain to keep blood sugar stable. That tipping point can arrive in childhood, adolescence, or well into adulthood. One large analysis found that 37 percent of people with Type 1 diabetes were diagnosed after age 30.
Certain gene combinations do raise the risk of developing Type 1, so there is a genetic component. But having those genes doesn’t guarantee you’ll get it, and the disease itself isn’t active at birth. A baby born with genes that predispose them to Type 1 might never develop it, or might develop it decades later. This is fundamentally different from neonatal diabetes, where the gene mutation directly causes the disease from the moment the pancreas starts functioning.
How Rare Neonatal Diabetes Is
Neonatal diabetes is uncommon. Estimates vary, but it affects roughly 1 in every 100,000 to 400,000 live births depending on the population studied. Because it’s so rare and because its symptoms overlap with more common conditions like feeding difficulties or failure to thrive, it can be missed initially. The availability of genetic testing has improved diagnosis rates significantly, and identifying the exact mutation early can spare a child years of unnecessary insulin injections if they’re a candidate for oral treatment instead.